Table 1.
Study population characteristics.
| Asthma (n = 11) | Healthy Controls (n = 10) | P value | |
|---|---|---|---|
|
| |||
| Age (years) | 10.5 (6 – 17) | 11.8 (6 – 18) | 0.50 |
| Sex (female) | 7/11 | 5/10 | 0.55 |
| FEV1 (% predicted) | 98.6 (80 – 122) | 101.1 (92 – 117) | 0.66 |
| FEV1/FVC | 0.81 (0.70 – 0.92) | 0.88 (0.81 – 0.98) | 0.02 |
| FeNO (ppb) | 23.5 (6 – 68) | 11.7 (6 – 27) | 0.10 |
| Total IgE (kIU/L) | 380.6 (1 – 1069) | 16.2 (1 – 52) | 0.01 |
| # (+) Allergen-Specific IgE Results | 2.82 (0 – 6) | 0 | 0.002 |
| Controller Treatment | 5/11 | ||
Five of the 11 children with asthma were on controller therapy: 3 children were on low dose fluticasone monotherapy, 1 child was on montelukast monotherapy, and 1 child was on low dose fluticasone and montelukast dual therapy. Mean values and ranges are listed. P values represent the result of unpaired t tests. FEV1, forced exhaled volume in one second; FVC, forced vital capacity; FeNO, fractional exhaled nitric oxide.